Addressing Unmet Need in Cardiovascular Disease

1:45 PM - 2:45 PM, Wednesday, June 5,2019 ・ 118B, Level 100
Cardiovascular-renal disease is the leading cause of death worldwide resulting in a massive societal burden. However, in recent years, we have seen a decline in the number of innovative cardiovascular treatments entering the marketing place. Why has the rate of development for new drugs in cardiovascular declined and what can be done to reverse this trend? This session will focus on strategies to tackle cardiovascular-renal diseases. Strategies to accelerate drug development in order to get treatments to patients quicker and more efficiently will be addressed, including incorporating digital health as an accelerator.
Moderator
photo
CEO
InCarda Therapeutics
Speakers
photo
CEO
InCarda Therapeutics
photo
Director of Stakeholder Engagement
Duke Clinical Research Institute
photo
Professor of Medicine
Fred Cobb
photo
Senior Advisor
Blackstone Life Sciences
photo
Global Head of Cardiometabolic Development
Novartis